Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid.

Jacobo Rogado RevueltaB ObispoC PanguaG Serrano-MonteroA Martín MarinoM Pérez-PérezA López-AlfonsoP GullónM Á Lara

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

Cancer patients are vulnerable to Covid-19 with an increase in complications. Combined hydroxychloroquine and azithromycin is presented as a good treatment option.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
healthcare
risk factors
adverse drug